Inventor
NATT FRANCOIS JEAN-CHARLES
CH12 patents
⚠️ This page may combine multiple inventors who share the name “NATT FRANCOIS JEAN-CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
6 patentsUS8344128B2Jan 1, 2013
Short interfering ribonucleic acid (siRNA) for oral administration
NOVARTIS AG38 citations96
US11008570B2May 18, 2021
3′ end caps for RNAi agents for use in RNA interference
NOVARTIS AG0 citations59
US10519446B2Dec 31, 2019
Organic compounds to treat hepatitis B virus
NOVARTIS AG1 citations58
US8957041B2Feb 17, 2015
Short interfering ribonucleic acid (siRNA) for oral administration
NOVARTIS AG0 citations51
US7786293B2Aug 31, 2010
Organic compounds
NOVARTIS AG0 citations51
US10227588B2Mar 12, 2019
3′end caps for RNAi agents for use in RNA interference
NOVARTIS AG0 citations48
NATT FRANCOIS JEAN-CHARLES
4 patentsUS8084600B2Dec 27, 2011
Short interfering ribonucleic acid (siRNA) with improved pharmacological properties
NATT FRANCOIS JEAN-CHARLES58 citations95
US8404832B2Mar 26, 2013
Short interfering ribonucleic acid (siRNA) for oral administration
NATT FRANCOIS JEAN-CHARLES27 citations94
US8404831B2Mar 26, 2013
Short interfering ribonucleic acid (siRNA) for oral administration
NATT FRANCOIS JEAN-CHARLES31 citations94
US9493771B2Nov 15, 2016
Short interfering ribonucleic acid (siRNA) for oral administration
NATT FRANCOIS JEAN-CHARLES0 citations50